Literature DB >> 2414569

Platelets and hypertension.

P Erne, T J Resink, E Bürgisser, F R Bühler.   

Abstract

Various physiological changes of platelets and the vascular smooth muscle cell are intimately related. For this reason, in addition to the number of features in common between platelets and vascular smooth muscle and the increased risk for thromboembolic complication in essential hypertension, the platelet was used as an experimental model for the investigation of calcium-dependent functional anomalies associated with hypertension. It is demonstrated, by a sequential analysis of receptor and postreceptor events, that platelets in hypertension exhibit (a) a greater adenylate cyclase-activation and c-AMP-accumulation response to PGE1, (b) an enhanced epinephrine-induced phosphorylation response, and (c) an increased shape change sensitivity to serotonin and epinephrine. The anomalies in these calcium-dependent processes are linked to elevated free calcium concentrations in platelets from hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414569     DOI: 10.1097/00005344-198500076-00017

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteers.

Authors:  K Winther; C M Jespersen; B Rydberg; G Thamsborg; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Modulators of platelet function in aging.

Authors:  Krishna S Iyer; Sanjana Dayal
Journal:  Platelets       Date:  2019-09-16       Impact factor: 3.862

3.  Comorbidity of asthma and hypertension may be mediated by shared genetic dysregulation and drug side effects.

Authors:  Olga Zolotareva; Olga V Saik; Cassandra Königs; Elena Yu Bragina; Irina A Goncharova; Maxim B Freidin; Victor E Dosenko; Vladimir A Ivanisenko; Ralf Hofestädt
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.